Rajput outfit announces Rs 1 cr for ‘burning Deepika Padukone alive’

New Delhi, Jan 9: A total of 10,349 people involved in the farming sector, including 5,763 farmers or cultivators, committed suicide in 2018, the National Crime Records Bureau (NCRB)'s report on 'Crime in India-2018' reveals.

The annual data was released around three months after the government released the NCRB report on 'Crime in India-2017'.

As per the latest data, of the 10,349 persons, who committed suicide in 2018, 4,586 were agricultural labourers.

The number of suicides in the farming sector in 2018 accounted for 7.7 per cent of the total suicide-victims (1,34,516) in the country, the NCRB data said.

Suicides in the country in 2018 rose to 1,34,516 from 1,29,887 in 2017.

The rate of suicides was up from 9.9 per cent in 2017 to 10.2 per cent in 2018. In 2017, a total of 10,655 farming sector-suicides were reported.

West Bengal, Bihar, Odisha, Uttarakhand, Meghalaya, Goa, Chandigarh, Daman and Diu, Delhi, Lakshadweep and Puducherry reported zero suicides of farmers or cultivators and agricultural labourers during 2018, said the report.

Udupi, June 10: Philanthropist and businessman Haji P K Abuswalih Kannangar passed away today at a private hospital in Mangaluru. He was 85. 

He was a resident of Pombathota house at Kannangar in Kaup taluk of Udupi district.

He was the proprietor of Green Store in Mudigere for past five decades and also was a coffee planter. 

He had served as the president of Muhayaddin Juma Masjid at Mudigere Hand-post in the past. He was also former president of Mudigere Taluk unit of Indian National Congress.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.